435
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Neurophysiological index as a biomarker for ALS progression: Validity of mixed effects models

, , , &
Pages 33-38 | Received 18 Jul 2010, Accepted 08 Oct 2010, Published online: 27 Jan 2011

References

  • Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8:94–109.
  • Winhammar JMC, Rowe DB, Henderson RD, Kiernan MC. Assessment of disease progression in motor neuron disease. Lancet Neurol. 2005;4:229–38.
  • deCarvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:344–52.
  • Bromberg MB, Brownell AA. Motor unit number estimation in the assessment of performance and function in motor neuron disease. Phys Med Rehabil Clin N Am. 2008;19:509–32.
  • Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436–46.
  • Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540–50.
  • deCarvalho M, Scotto M, Lopes A, Swash M. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis. Muscle Nerve. 2003;28:630–3.
  • deCarvalho M, Scotto M, Lopes A, Swash M. Quantitating progression in ALS. Neurology. 2005;64:1783–5.
  • Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
  • deCarvalho M, Lopes A, Scotto M, Swash M. Reproducibility of neurophysiological and myometric measurement in the ulnar nerve-abductor digiti minimi system. Muscle Nerve. 2001;24:1391–5.
  • Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics. 1982;38:963–74.
  • Gordon PH, Cheung YK, Levin B, Andrew H, Doorish C, Macarthur RB, . A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler. 2008;9:212–22.
  • Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, . Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol. 2007;6:1045–53.
  • Moore DH, Miller RG. Improving efficiency of ALS clinical trials using lead-in designs. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:S57–60.
  • R Development Core Team. R: a language and environment for statistical computing. 2.11.0. Vienna, Austria; 2010.
  • Pinheiro J, Bates D, DebRoy S, Sarkar D, Team RC. nlme: linear and non-linear mixed effects models. R package version 3.1-96; 2009.
  • Eisen A. Amyotrophic lateral sclerosis: a 40-year personal perspective. J Clin Neurosci. 2009;16:505–12.
  • Wohlfart G. Collateral regeneration from residual motor nerve fibres in amyotrophic lateral sclerosis. Neurology. 1957;7:124–34.
  • Hansen S, Ballantyne JP. A quantitative electrophysiological study of motor neuron disease. J Neurol Neurosurg Psychiatry. 1978;41:773–83.
  • Sobue G, Matsuoka Y, Mukai E, Takayanagi T, Sobue I. Pathology of myelinated fibres in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis. J Neurol Sci. 1981;50:413–21.
  • Aggarwal S, Cudkowicz M. ALS drug development: reflections from the past and a way forward. Neurotherapeutics. 2008;5:516–27.
  • Vucic S, Kiernan MC. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78:849–52.
  • Buschbacher RM. Tibial nerve F-waves recorded from the abductor hallucis. Am J Phys Med Rehabil. 1999;78:S43–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.